10-Q: Balance Labs Reports Increased Net Loss in Q3 2024 Amidst Going Concern Uncertainty
Quarterly Report
Balance Labs reported a widened net loss for the third quarter of 2024 and faces substantial doubt about its ability to continue as a going concern.
Summary
- Balance Labs, a consulting firm, reported a net loss of $192,837 for the three months ended September 30, 2024, compared to a net loss of $68,735 for the same period in 2023.
- The company's net loss for the nine months ended September 30, 2024, was $410,480, compared to $252,768 for the same period in 2023.
- The increased losses are primarily attributed to higher salary expenses and unrealized losses on available-for-sale securities.
- The company's cash and cash equivalents decreased to $30,407 as of September 30, 2024, from $112,809 at the end of 2023.
- Balance Labs has a working capital deficit of $4,953,363 as of September 30, 2024, and an accumulated deficit of $5,765,578.
- The company's auditors have expressed substantial doubt about its ability to continue as a going concern.
- Management plans to seek additional capital within the next twelve months to sustain operations.
Sentiment
Score: 2
Explanation: The document paints a very negative picture due to the significant increase in net losses, the substantial working capital deficit, the going concern warning, and the numerous defaults on debt. The company's financial situation is precarious, and its future is highly uncertain.
Positives
- General and administrative expenses decreased by 43% for the three months ended September 30, 2024, compared to the same period in 2023.
- The company is actively pursuing new client relationships to improve its financial position.
- The company plans to formalize relationships with subcontractors to offer turn-key business development services.
Negatives
- The company experienced a significant increase in net loss for both the three and nine-month periods ending September 30, 2024.
- The company's cash reserves have significantly decreased, raising concerns about its short-term liquidity.
- The company has a substantial working capital deficit and accumulated deficit.
- The company's auditors have expressed substantial doubt about its ability to continue as a going concern.
- The company has significant related party debt, much of which is in default.
- The company's disclosure controls and procedures were deemed ineffective due to material weaknesses.
Risks
- The company faces substantial doubt about its ability to continue as a going concern without additional funding.
- The company's reliance on related party debt and the default status of many of these loans pose a significant risk.
- The company's lack of a diversified client base and limited resources could lead to temporary cash flow imbalances.
- The company's material weaknesses in internal controls could lead to misstatements in financial reporting.
- The company's ability to secure additional financing is uncertain, and any financing may come with restrictions or dilution.
- The company's marketing plan may not be successful in attracting new clients.
Future Outlook
The company plans to seek additional capital within the next twelve months to sustain operations and intends to formalize relationships with subcontractors to offer turn-key business development services. The company also expects to begin a marketing campaign to market and sell its services.
Management Comments
- Management plans to seek to raise additional capital within the next twelve months that is expected to sustain its operations for the next year.
- Management believes that the material weaknesses set forth above were the result of the scale of our operations and are intrinsic to our small size.
- Management believes these weaknesses did not have a material effect on our financial results and intends to take remedial actions upon receiving funding for the Company's business operations.
Industry Context
The company operates in the consulting industry, which is characterized by providing business development and consulting services to start-up and development-stage companies. The company's challenges with profitability and liquidity are not uncommon for early-stage consulting firms, especially those with limited resources and a small client base.
Comparison to Industry Standards
- It is difficult to compare Balance Labs directly to industry standards due to its unique business model and early stage of development.
- Many consulting firms, especially those focused on start-ups, face similar challenges with cash flow and profitability in their early years.
- However, the severity of Balance Labs' financial situation, including the going concern warning and significant related party debt, is concerning compared to more established consulting firms.
- The lack of revenue generation and reliance on debt financing is not typical for a sustainable consulting business.
- The company's internal control weaknesses are also a significant concern compared to industry best practices.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Controls | The company identified material weaknesses in its internal controls, including functional controls, lack of an audit committee, and inadequate segregation of duties. | 2024-09-30 | These weaknesses could lead to misstatements in financial reporting and require remedial actions. |
Related Party Transactions
- The company has significant related party transactions, including loans from the CEO and companies controlled by the CEO, as well as convertible notes payable to related parties.
- Many of these related party loans and notes are in default.
Stakeholder Impact
- Shareholders face significant risk due to the company's financial instability and the potential for substantial dilution if equity financing is pursued.
- Employees may be impacted by potential cost reductions or the cessation of operations.
- Customers may be affected by the company's ability to provide services if it faces financial difficulties.
- Creditors, particularly related parties, face the risk of not being repaid due to the company's default on loans.
Next Steps
- The company plans to seek additional capital within the next twelve months.
- The company intends to formalize relationships with subcontractors.
- The company expects to begin a marketing campaign to market and sell its services.
- Management will reassess the segregation of duties at the end of the fiscal year.
Key Dates
| Date | Description |
|---|---|
| 2014-06-05 | Balance Labs, Inc. was incorporated. |
| 2016-04-01 | The company received $500,000 from Newell Trading Group in exchange for a convertible debenture. |
| 2019-10-03 | Newell Trading Group assigned its rights and interests in the convertible debenture to the Sammy Farkas Foundation Inc. |
| 2021-01-29 | Balance Labs Inc. made a loan to Four Acquisitions Ltd. and received 20% ownership of Pharmacy No, 27, Ltd. |
| 2021-06-27 | The company received $50,000 from the CEO in exchange for a convertible promissory note. |
| 2023-10-31 | A new agreement with the CEO was effective, paying $10,000 per month. |
| 2024-09-30 | End of the quarterly period for this report. |
| 2024-11-11 | Date of outstanding shares calculation. |
| 2024-11-19 | Date of report filing. |
Keywords
consulting, financial results, net loss, going concern, related party debt, working capital, internal controls, capital raise, liquidity, business development
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.